These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 21564163

  • 1. Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man.
    Coiro V, Volpi R, Casti A, Maffei ML, Stella A, Volta E, Chiodera P.
    Br J Clin Pharmacol; 2011 Jun; 71(6):951-5. PubMed ID: 21564163
    [Abstract] [Full Text] [Related]

  • 2. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Gianotti L, Broglio F, Benso A, Deghenghi R, Camanni F, Ghigo E.
    Neuroendocrinology; 1998 May; 67(5):310-6. PubMed ID: 9641612
    [Abstract] [Full Text] [Related]

  • 3. Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans.
    Giordano R, Grottoli S, Brossa P, Pellegrino M, Destefanis S, Lanfranco F, Gianotti L, Ghigo E, Arvat E.
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):314-20. PubMed ID: 12919154
    [Abstract] [Full Text] [Related]

  • 4. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV.
    Clin Exp Pharmacol Physiol; 1995 Sep; 22(6-7):441-3. PubMed ID: 8582096
    [Abstract] [Full Text] [Related]

  • 5. Oxytocin reduces exercise-induced ACTH and cortisol rise in man.
    Coiro V, Passeri M, Davoli C, Bacchi-Modena A, Bianconi L, Volpi R, Chiodera P.
    Acta Endocrinol (Copenh); 1988 Nov; 119(3):405-12. PubMed ID: 2847472
    [Abstract] [Full Text] [Related]

  • 6. Hypoglycemia-induced inhibition of LH and stimulation of ACTH secretion in the rhesus monkey is blocked by alprazolam.
    Van Vugt DA, Washburn DL, Farley AE, Reid RL.
    Neuroendocrinology; 1997 May; 65(5):344-52. PubMed ID: 9158066
    [Abstract] [Full Text] [Related]

  • 7. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
    Grottoli S, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, DeStefanis S, Camanni F, Ghigo E, Arvat E.
    J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
    [Abstract] [Full Text] [Related]

  • 8. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [Abstract] [Full Text] [Related]

  • 9. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of naloxone-stimulated adrenocorticotropin release by alprazolam in myotonic dystrophy patients.
    Joyner JM, Grice JE, Hockings GI, Torpy DJ, Crosbie GV, Walters MM, Jackson RV.
    J Neuroendocrinol; 1998 May; 10(5):391-5. PubMed ID: 9663654
    [Abstract] [Full Text] [Related]

  • 11. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
    Grottoli S, Giordano R, Maccagno B, Pellegrino M, Ghigo E, Arvat E.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
    [Abstract] [Full Text] [Related]

  • 12. Free fatty acids inhibit adrenocorticotropin and cortisol secretion stimulated by physical exercise in normal men.
    Coiro V, Casti A, Rubino P, Manfredi G, Maffei ML, Melani A, Saccani Jotti G, Chiodera P.
    Clin Endocrinol (Oxf); 2007 May; 66(5):740-3. PubMed ID: 17381494
    [Abstract] [Full Text] [Related]

  • 13. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV.
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [Abstract] [Full Text] [Related]

  • 14. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, Broglio F, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2611-5. PubMed ID: 10443648
    [Abstract] [Full Text] [Related]

  • 15. Cortisol and ACTH release in dairy cows in response to machine milking after pretreatment with morphine and naloxone.
    Tancin V, Schams D, Kraetzl WD.
    J Dairy Res; 2000 Nov; 67(4):467-74. PubMed ID: 11131061
    [Abstract] [Full Text] [Related]

  • 16. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ, Jackson RV, Grice JE, Hockings GI, Crosbie GV, Walters MM.
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):157-61. PubMed ID: 8039271
    [Abstract] [Full Text] [Related]

  • 17. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
    Inder WJ, Hellemans J, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
    J Clin Endocrinol Metab; 1995 Jan; 80(1):244-8. PubMed ID: 7829620
    [Abstract] [Full Text] [Related]

  • 18. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
    Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.
    Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
    [Abstract] [Full Text] [Related]

  • 19. Effect of naloxone on oxytocin-induced cortisol decrease in normal men.
    Coiro V, Chiodera P, Rossi G, Volpi R, Salvi M, Camellini L, Roti E.
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):261-5. PubMed ID: 2982243
    [Abstract] [Full Text] [Related]

  • 20. The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress.
    Chong RY, Oswald L, Yang X, Uhart M, Lin PI, Wand GS.
    Neuropsychopharmacology; 2006 Jan; 31(1):204-11. PubMed ID: 16123758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.